Overview

Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem

Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
A study to compare the safety and efficacy of moxifloxacin to ertapenem in patients with intra-abdominal infections.
Phase:
Phase 3
Details
Lead Sponsor:
Bayer
Treatments:
Ertapenem
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination